Memorandum
To: Market Participants
From: NZX Product Operations
Date: Wednesday, 15 February 2023
Subject: Ryman Healthcare Limited (RYM) – Accelerated Offer and on-market trading of Retail Entitlements
Message:
As per its announcement of 15 February 2023, Ryman Healthcare Limited (RYM) is undertaking a fully underwritten 1 for 2.81 Pro Rata Accelerated Renounceable Entitlement Offer, with Retail Entitlements to be quoted and traded on the NZX Main Board.
Under the Offer, Eligible Retail Shareholders are being invited to subscribe for New Shares, at an Offer Price of $5.00 per share.
The Offer is open to Eligible Shareholders and Eligible Purchasers of Entitlements in New Zealand, Australia and a limited number of other jurisdictions. Information about the Offer, including on the eligibility criteria and how to participate, is set out in the Offer Document announced today by RYM. The Offer Document can be found here: www.nzx.com/announcements/406679
The Retail Entitlements will be trading under the ticker code “RYMRA” and ISIN “NZRYME0002S2”. RYMRA will be trading on a deferred settlement basis from Monday, 20 February until COB Thursday, 23 February. Settlement for these trades will occur on Tuesday, 28 February. Trading in RYMRA will be on a normal settlement basis from Friday, 24 February until the last date of Retail Entitlement trading on Tuesday, 28 February 2023.
A Quotation Notice for the Retail Entitlements has been released today.
A timetable of retail events is attached.
A timetable of trading halts relating to the offer is also attached.
Please contact NZX Product Operations on +64 4 496 2853 or [email protected] with any queries.
ENDS
Tesla's 14% drop again highlighted the general state of global market uncertainty.
The original delivery date of the International Convention Centre was January 2019.
Private equity investing will benefit both KiwiSavers and business, fund manager says.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details